All terms in HP
| Label | Id | Description |
|---|---|---|
| Abnormal circulating follicle-stimulating hormone level | HP_0030346 | [An anomaly of the circulating level of follicle-stimulating hormone (FSH).] |
| regulation of drinking behavior | NBO_0000064 | |
| Combined immunodeficiency | HP_0005387 | [A group of phenotypically heterogeneous genetic disorders characterized by profound deficiencies of T- and B-cell function, which predispose the patients to both infectious and noninfectious complications.] |
| positive regulation of serotonin secretion | GO_0014064 | [Any process that activates or increases the frequency, rate or extent of the regulated release of serotonin.] |
| positive regulation of ion transport | GO_0043270 | [Any process that activates or increases the frequency, rate or extent of the directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
| regulation of serotonin secretion | GO_0014062 | [Any process that modulates the frequency, rate or extent of the regulated release of serotonin.] |
| regulation of ion transport | GO_0043269 | [Any process that modulates the frequency, rate or extent of the directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
| negative regulation of serotonin secretion | GO_0014063 | [Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of serotonin.] |
| negative regulation of ion transport | GO_0043271 | [Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
| Defective B cell activation | HP_0005384 | [A reduced ability of a B cell to become activated, i.e., the change in morphology and behavior of] |
| Recurrent meningococcal disease | HP_0005381 | [Recurrent infections by Neisseria meningitidis (one of the most common causes of bacterial meningitis), which is also known as meningococcus.] |
| Recurrent opportunistic infections | HP_0005390 | [Increased susceptibility to opportunistic infections, as manifested by recurrent episodes of infection by opportunistic agents, i.e., by microorganisms that do not usually cause disease in a healthy host, but are able to infect a host with a compromised immune system.] |
| Decreased circulating luteinizing hormone level | HP_0030344 | [A reduction in the circulating level of luteinizing hormone (LH).] |
| Decreased circulating gonadotropin level | HP_0030339 | [A reduction of the circulating level of a gonadotropin, that is, of a protein hormone secreted by gonadotrope cells of the anterior pituitary of vertebrates. The primary gonadotropins are luteinizing hormone (LH) and follicle-stimulating hormone (FSH).] |
| Decreased circulating follicle stimulating hormone level | HP_0030341 | [A reduction of the circulating level of follicle-stimulating hormone (FSH).] |
| obsolete Increased circulating gonadotropin level | HP_0030340 | |
| Absence of CD4-positive, CD25-positive regulatory T cells | HP_0030336 | [Lack of CD4+CD25+ T regulatory cells.] |
| Abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell count | HP_0030335 | [A deviation from the normal count of CD4-positive, CD25-positive, alpha-beta regulatory T cells.] |
| Elevated CD4-positive, CD25-positive regulatory T cell count | HP_0030337 | [An increased number of CD4-positive, CD25-positive regulatory T cells.] |
| Abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology | HP_0030334 | [A structural anomaly of a CD4-positive, CD25-positive, alpha-beta T cell. These cells are regulatory T cells.] |